114 related articles for article (PubMed ID: 1441611)
1. High-performance tandem mass spectrometry in metabolism studies.
Fenselau C; Smith PB
Xenobiotica; 1992; 22(9-10):1207-19. PubMed ID: 1441611
[TBL] [Abstract][Full Text] [Related]
2. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
3. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
4. The interaction of glutathione with 4-hydroxycyclophosphamide and phosphoramide mustard, studied by 31P nuclear magnetic resonance spectroscopy.
Dirven HA; Venekamp JC; van Ommen B; van Bladeren PJ
Chem Biol Interact; 1994 Dec; 93(3):185-96. PubMed ID: 7923439
[TBL] [Abstract][Full Text] [Related]
5. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
6. Comparative disposition of phosphoramide mustard and other cyclophosphamide metabolites in the mouse using the Salmonella/mutagenesis assay.
Suling WJ; Struck RF; Woolley CW; Shannon WM
Cancer Treat Rep; 1978 Sep; 62(9):1321-8. PubMed ID: 356985
[No Abstract] [Full Text] [Related]
7. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
8. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
10. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
11. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
[TBL] [Abstract][Full Text] [Related]
12. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry.
Kalhorn TF; Howald WN; Cole S; Phillips B; Wang J; Slattery JT; McCune JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):105-13. PubMed ID: 16581318
[TBL] [Abstract][Full Text] [Related]
14. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
[TBL] [Abstract][Full Text] [Related]
15. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.
McGown AT; Fox BW
Cancer Chemother Pharmacol; 1986; 17(3):223-6. PubMed ID: 3742706
[TBL] [Abstract][Full Text] [Related]
16. Identification of glutathione conjugates of the dimethyl ester of bilirubin in the bile of Gunn rats.
Odell GB; Mogilevsky WS; Smith PB; Fenselau C
Mol Pharmacol; 1991 Oct; 40(4):597-605. PubMed ID: 1681418
[TBL] [Abstract][Full Text] [Related]
17. Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
Kwon CH; Maddison K; LoCastro L; Borch RF
Cancer Res; 1987 Mar; 47(6):1505-8. PubMed ID: 3815352
[TBL] [Abstract][Full Text] [Related]
18. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of oxazaphosphorines.
Sladek NE
Pharmacol Ther; 1988; 37(3):301-55. PubMed ID: 3290910
[No Abstract] [Full Text] [Related]
20. N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard.
Jiang Y; Hu L
Bioorg Med Chem Lett; 2008 Jul; 18(14):4059-63. PubMed ID: 18556201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
